ARK Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • ARK Diagnostics's estimated annual revenue is currently $12.6M per year.(i)
  • ARK Diagnostics's estimated revenue per employee is $251,000

Employee Data

  • ARK Diagnostics has 50 Employees.(i)
  • ARK Diagnostics grew their employee count by 4% last year.

ARK Diagnostics's People

NameTitleEmail/Phone
1
VP, OperationsReveal Email/Phone
2
Director Product DevelopmentReveal Email/Phone
3
Sr. Director, Strategy and InnovationReveal Email/Phone
4
Senior Manager, Marketing and ServiceReveal Email/Phone
5
Sr. Manager, Special ProjectsReveal Email/Phone
6
Senior Quality Assurance SpecialistReveal Email/Phone
7
Sales ConsultantReveal Email/Phone
8
Scientist IReveal Email/Phone
9
R&D Scientist IReveal Email/Phone
10
Pharmaceutical Sciences Specialist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.1M9619%N/AN/A
#2
$9.5M3812%N/AN/A
#3
$4M16-11%N/AN/A
#4
$7.8M31-3%N/AN/A
#5
$5M20-5%N/AN/A
#6
$49.9M199-8%N/AN/A
#7
$16.8M67-17%$63.2MN/A
#8
$9.3M37-7%N/AN/A
#9
$36.6M14622%N/AN/A
#10
$64.3M2053%$502MN/A
Add Company

What Is ARK Diagnostics?

ARK Diagnostics Inc. designs, manufactures, and distributes in vitro diagnostic products. ARK’s proprietary assays accurately measure drug levels in biological fluids. Clinicians use these measurements to guide dosing decisions for safe, effective, and personalized drug therapy. By optimizing drug levels, clinicians improve outcomes, reduce toxicity, and lower healthcare costs. ARK is dedicated to improving the quality of patient health through better therapeutic drug management. (ARK Diagnostics, Inc. seeks regulatory clearance in the United States and Internationally.)

keywords:N/A

N/A

Total Funding

50

Number of Employees

$12.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.6M50-7%N/A
#2
$11.6M502%N/A
#3
$11M5014%N/A
#4
$9.8M509%N/A
#5
$5.8M5043%N/A